
RARE
Ultragenyx Pharmaceutical Inc
Biotechnology
Ultragenyx Pharmaceutical Inc (RARE) Financials
We don't have SEC-filed financials for RARE yet. Explore its overview, insider activity, and news below.
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.